Medication info
Depoterim Sustained-Release Tablets 10/500 mg (Teneligliptin Hydrochloride Hydrate, Metformin Hydrochloride)

Depoterim Sustained-Release Tablets 10/500 mg (Teneligliptin Hydrochloride Hydrate, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
IYON Pharmaceutical Co., Ltd.
Appearance
Orange egg-shaped sustained-release film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201305 · Approved 2022.04.04 · Insurance code 658604720

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient’s current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who are unable to achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient’s current metformin dose. For patients switching to this medicine from concomitant therapy with teneligliptin and metformin, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When administered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because any change may affect glycemic control, all changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
IYON Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. By taking Teneligliptin and Metformin together, it enhances the effects of dietary and exercise therapies, helping patients manage their blood sugar more effectively. Thus, this medication plays a significant role in improving blood sugar control.

How to take

Adult dose

The dose of this medicine should be determined based on each patient’s current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who are unable to achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient’s current metformin dose. For patients switching to this medicine from concomitant therapy with teneligliptin and metformin, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When administered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because any change may affect glycemic control, all changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is primarily used for the treatment of diabetes and contains two active ingredients. First, it should only be given to patients with normal kidney function and should not be used in patients with moderate to severe renal impairment. Second, it should not be administered in cases where kidney function is rapidly deteriorating due to severe heart failure, acute myocardial infarction, sepsis, etc. Third, this medication should be discontinued before examinations that use radiographic iodine contrast and should be resumed only after confirming normal kidney function post-examination. Fourth, it is not to be used in patients with type 1 diabetes or those with metabolic acidosis such as lactic acidosis or diabetic ketoacidosis. Fifth, it should not be administered to individuals with allergies to its ingredients. Sixth, in patients with severe infections, serious trauma, preoperative or postoperative conditions, malnutrition, liver dysfunction, lung impairment, excessive alcohol intake, etc., the administration should be temporarily withheld or used cautiously. Seventh, this medication may cause hypoglycemia, so caution is needed for hypoglycemic symptoms when used in conjunction with insulin or other hypoglycemic agents. Eighth, if symptoms such as abdominal pain, vomiting, or constipation persist, there may be a risk of pancreatitis or gastrointestinal disorders, and consultation with a physician is advisable. Ninth, it is generally recommended that pregnant women, women with potential for pregnancy, and nursing mothers do not use this medication. Tenth, the elderly may have diminished kidney function, thus requiring regular monitoring of kidney function and possible dosage adjustment. Lastly, during treatment with this medication, alcohol consumption should be avoided, and if symptoms of lactic acidosis or hypoglycemia (fatigue, muscle pain, difficulty breathing, weakness, abdominal pain, cold sweat, trembling, confusion, etc.) occur, a physician should be notified immediately.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • dermatomyositis
  • acute pancreatitis
  • dizziness
Show 160 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyp
  • colon polyp
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • elevated amylase
  • elevated lipase
  • increased AST (GOT)
  • increased ALT (GPT)
  • elevated GGT
  • increased ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium levels
  • lethargy
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory tract infection
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory tract infection
  • rhinitis
  • sweating
  • diabetic retinopathy
  • vision impairment
  • cough
  • pulmonary congestion
  • shortness of breath
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophils
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • urticaria
  • hepatic coma
  • sensory disturbance
  • sensory loss
  • tension headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • positional dizziness
  • muscle weakness
  • low back pain
  • limb pain
  • lumbar spinal canal stenosis
  • tendonitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle spasm
  • foot deformity
  • hypertrophic osteoarthropathy
  • bursitis
  • spinal osteoarthritis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • gastroenteritis
  • influenza
  • uterine abscess
  • subcutaneous abscess
  • vomiting
  • chronic gastritis
  • upper abdominal pain
  • mouth sores
  • esophagitis
  • gastrointestinal motility disorder
  • reduced gastrointestinal motility
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • increased blood sugar
  • abnormal sputum
  • toxic hepatitis
  • chronic cholecystitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • bruise
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina pectoris
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure ulcer
  • hearing loss
  • endolymphatic hydrops
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • anemia
  • atrial fibrillation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and it is best kept at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medicine's efficacy.

Appearance and packaging

Appearance

Orange egg-shaped sustained-release film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.